Dry Tamponade? What Is It? And What Do I Do About It?
Advertisement Top User Menu Register Login Main navigation …
Advertisement Top User Menu Register Login Main navigation …
Welcome to cardiology’s jolliest—and most socially acceptable forum—for proving you paid attention to the top news of 2024! Submit your crossword answers, whether you’ve answered…
Welcome to cardiology’s jolliest—and most socially acceptable forum—for proving you paid attention to the top news of 2024! Submit your crossword answers, whether you’ve answered…
Venous thromboembolism is a risk with several contemporary HRT formulations, consistent with earlier data.
The result calls into question the prospects of FDA approval for the Acurate neo2 valve, which is already in use globally.
UK Biobank data suggest it makes sense to be vigilant about CV prevention even years after SARS-CoV-2. Hooman Allayee, PhD, explains why.
News from the American Heart Association 2024 Scientific Sessions took seven of the 10 top slots this month.
Two AVR patients, Julie and Julian “JP” Jones, join Shelley Wood and cardiologists Megan Coylewright and Benjamin Galper to offer their perspectives on TAVI and…
Acoramidis becomes the second drug ever approved for this condition, based on the results of the ATTRibute-CM trial.
This month: Sleep talking and stroke risk, pregnancy-related VTE recurrence, long-term tirzepatide benefits, and more.
(UPDATED) Pooled data from three NUDGE-FLU trials show targeted messaging about CV benefits is helpful in these high-risk patients.